Blog - Page 3983 of 5666

MondayNov 30, 2009 1:38 pm

Li3 Energy, Inc. (LIEG.OB) to Acquire Puna Lithium Corporation of Chile

Li3 Energy Inc. is pursuing a business strategy to acquire a portfolio of lithium brine deposits in the Americas for the purpose of development and production of lithium. Lithium is used extensively in many clean and green energy applications such as batteries. The company announced today that it has signed a letter of intent to acquire Puna Lithium Corporation. Puna has an option to acquire up to 85% of 90,000 acres of salar property in Argentina. More importantly, Puna has an option to acquire up to an aggregate 80% interest in 123,000 acres of prime Chilean salar ground located across…

MondayNov 30, 2009 12:35 pm

Trans-Orient Petroleum Ltd. (TOPLF.OB) Posts FY09 Highlights and Future Projections

Trans-Orient Petroleum Ltd. today announced it has filed its fiscal-year financial results for the year ended July 31, 2009, and notes significant highlights for the year, including preparations for its initial drilling campaign, progress of its business partnership in the works, and independent reserves reports. "It was a busy year for Trans-Orient in New Zealand, preparing for our initial drilling campaign targeting both conventional and unconventional shale prospects. We are also very excited as we move closer to completion of our strategic business combination with TAG Oil Ltd. (TSX-V: TAO), anticipated to close in mid-December 2009,” Trans-Orient CEO Garth Johnson…

MondayNov 30, 2009 11:56 am

Cannabis Science, Inc. (CBIS.OB) Gets New Advisory Board Members

Cannabis Science Inc., best known for its research and development in the medical uses of marijuana, has announced that Dr. Ben Johnson, Dr. Allan Shackleford, and Dr. William Courtney, have all accepted membership on the company’s recently formed Scientific Advisory Board. Already serving on the board are Dr. Mitch Earlywine, Ph.D. and Dr. Ritchard Fishman, M.D. The addition of several prominent scientists and physicians is expected to help hasten the company’s FDA submissions. Dr. Ben Johnson is a complementary and alternative medicine physician, with a degree in Osteopathy in addition to M.D. and N.M.D. degrees. He is the founder and…

MondayNov 30, 2009 11:01 am

Gabelli Equity Trust (GAB) Continues its Solid and Stable Run in the Income Sector

Following the in-flows and out-flows of the mutual fund industry offers insight as to what the general investor is up-to. As might be expected, in a poor economy, investment monies tend to flow out of mutual funds. This reality is the current trend with investment capital leaving funds. The astute investor, however, may see this as an opportunity. Not following the "herd" is how profit is made. The opportunities are apparent and transparent, which is the advantage of mutual funds. An investor can easily see where and what is being invested in. Commodities, "blue-chips" or a blend is the choice.…

MondayNov 30, 2009 10:24 am

Muscle Flex Inc. (MFLI.PK) Announces Acquisition of Web Domain and Launches an Updated Web Site

Muscle Flex Inc. announced this morning that it has acquired the web domain www.MuscleFlex.com and has launches a new updated site ahead of the national release of the Beagle StepFit commercial. To visit the new site, click on the following link: www.MuscleFlex.com "Acquiring the MuscleFlex.com web domain was an important step in ensuring that all web traffic generated from our advertising is captured with as little bleeding as possible," commented Danny Alex, CEO of Muscle Flex Inc. "I regard our web traffic to be one of our most valuable assets and now with the acquisition of MuscleFlex.com, Muscle Flex Inc.…

MondayNov 30, 2009 9:48 am

VIASPACE, Inc. (VSPC.OB) Announces Filing of Amended Form S-1

VIASPACE Inc., a clean energy company growing Giant King(TM) Grass as a low-carbon, renewable energy crop, announced that on November 25, 2009, it filed an amended Form S-1 with the Securities and Exchange Commission to list its majority-owned subsidiary, VIASPACE Green Energy Inc. (VGE), as a separately reporting public company. VGE’s shares are expected to be traded on the OTC Bulletin Board. VIASPACE Inc. anticipates that its majority ownership in VIASPACE Green Energy, current management and operations of VGE, and VGE's focus on renewable energy will remain unchanged. VIASPACE Chief Executive Carl Kukkonen reiterated that with separate reporting, VGE's business,…

MondayNov 30, 2009 9:41 am

TapImmune, Inc. (TPIV.OB) Secures Additional Funding

TapImmune Inc., a biotechnology company specializing in the development of immunotherapeutic vaccines for cancer and infectious diseases, announced last week that within the last 60 days the company secured an additional $600,000 in equity funding, bringing the total for the last six months of 2009 to over $1,000,000. The recent investors acquired $.80 units with each unit comprised of one share and one warrant exercisable at $1.20 for a period of 5 years. The recent restructuring taken place at TapImmune has provided a more secure framework from which to pursue investment and industry partnerships. The company is dedicated to working…

MondayNov 30, 2009 9:03 am

Ironwood Gold Corp. (IROG.OB) Makes National News with the Acquisition of Additional Mineral Rights at Cobalt Canyon Gold Project

One company that has been stirring up a storm in the desert is the Arizona based Ironwood Gold Corporation. A noted mineral exploration and development company, Ironwood Gold is building a unique portfolio of prospective properties containing known deposits of strategic precious metals in mine-friendly North America. Today, Ironwood Gold took a major step towards enhancing their future with the acquisition of mineral rights at Cobalt Canyon Gold Project in Nevada which contain 32 additional Federal Iode mining claims. With the additional 32 claims covering 274 acres, the project, which was originally believed to cover a total of 422 acres,…

MondayNov 30, 2009 8:57 am

Incyte Corp. (INCY) Inks License Agreement with Novartis for Oncology Treatment

Incyte Corp. is a development company focused on oncology, inflammation and diabetes treatments. The company recently announced an agreement with Novartis regarding two of its investigational hemotology-oncology therapies. INCB18424 is an oral inhibitor in phase III development for myelofibrosis, a potentially fatal condition that includes bone marrow failure, splenic enlargement and debilitating constitutional symptoms. INCB28060 is an oral inhibitor that will soon be in phase I development as treatment for multiple cancers. The license and collaboration agreement calls for Incyte to keep the exclusive rights for the development and commercialization of INCB18424 in the United States. Novartis will be responsible…

MondayNov 30, 2009 8:48 am

Derma Sciences, Inc. (DSCI.OB) Plans Reverse Stock Split

Last week, specialty medical device and pharmaceutical company Derma Sciences, Inc. announced that its shareholders granted Derma Sciences' Board of Directors the authority to implement a reverse stock split in the range of 1-to-5 and 1-to-10. Derma Sciences' Board of Directors anticipates the reverse split to occur in the near future. The precise reverse split ratio will be determined in accordance with the then prevailing market conditions. For the 20-day period following implementation of the reverse split, Derma Sciences' ticker symbol will be "DSCID" to reflect the post-split price. Following that period, the ticker symbol will revert to "DSCI." Ed…

Site Search

Company Search